Karen has held a number of positions of increasing responsibility in academia, pharmaceutical clinical and discovery research over the last 25 years. Cross-trained in clinical pharmacology, TA biology, drug discovery and business development and licensing, Karen has extensive knowledge and experience in execution and leadership across the drug development R&D value chain.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Schrödinger | Chief Biomedical Scientist | May 1, 2018 | — | Detail |